From the Guidelines
Plawuenel is not a recognized medication name, however, it's possible that it may be a misspelling or variation of the medication "Plaquenil", which is also known as hydroxychloroquine.
Potential Risks
As a precaution, hydroxychloroquine can be a potentially dangerous drug if not used properly, especially at high doses or for extended durations 1.
- High dose and long duration of use are the most significant risks, with other major factors including concomitant renal disease, or use of tamoxifen 1.
- It's essential to use hydroxychloroquine under the guidance of a healthcare professional, with typical doses ranging from 200 to 400 mg per day, and treatment durations varying depending on the condition being treated.
- If you are taking or considering taking Plaquenil or any other medication, it's crucial to follow the recommended dosage and consult with a healthcare professional to discuss potential risks and benefits.
Important Considerations
The provided evidence does not directly mention Plawuenel, but it discusses the potential risks associated with immunosuppressive drugs, including those that may be related to Plaquenil 1.
- Many of these agents can affect multiple organ systems and may have synergistic effects when used in combination with other immunosuppressive agents.
- Infection is a major complication that can occur as a consequence of administering these immunosuppressive drugs, and reactivation of latent disease or the onset of new infection during the course of treatment present significant risks for patients 1.
From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
Medication Errors and Safety
- Medication errors can occur due to various factors, including prescribing faults, prescription errors, and administration errors 2
- Look-alike or sound-alike medication names can lead to errors, and solutions such as typographic tweaks and computerized physician order entry can help prevent these errors 3
Plaquenil (Hydroxychloroquine) Therapy
- Hydroxychloroquine (Plaquenil) is used to treat auto-immune conditions and malaria, but can cause ocular side-effects, including irreversible macular damage 4
- The Royal College of Ophthalmologists, UK (RCO) has recommended against routine monitoring of patients receiving quinoline therapy due to the low incidence of retinal complications 4
Medication Identification and Error Prevention
- The Medication Sketch Artist is a graphically interfaced medication identification system that can aid in physician-patient communication and reduce medication errors 5
- Automated measures of similarities between medication names can help predict the potential for look-alike and sound-alike medication errors 6
Plawuenel (Assumed to be Plaquenil)
- There is no direct information available on "Plawuenel", but it is assumed to be a misspelling of "Plaquenil" (hydroxychloroquine)
- As Plaquenil can cause ocular side-effects, it is essential to monitor patients undergoing this therapy and take proactive measures to prevent medication errors 4